Search This Blog

Thursday, November 14, 2019

Aprea Therapeutics EPS beats by $0.59

Aprea Therapeutics (NASDAQ:APRE): Q3 GAAP EPS of -$5.29 beats by $0.59.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)